TickerFacts.

A business in context

BCRX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-31 · 0000882796-26-000065

  2. 4 · Ownership change

    Report date 2026-08-31 · 0000882796-26-000063

  3. 4 · Ownership change

    Report date 2026-08-31 · 0000882796-26-000061

  4. 4 · Ownership change

    Report date 2026-08-31 · 0000882796-26-000059

  5. 4 · Ownership change

    Report date 2026-08-31 · 0000882796-26-000057

  6. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-053300

  7. 8-K · Current report

    Report date 2026-08-05 · 0001171843-26-005223 · Items 2.02,7.01,9.01

  8. 8-K/A · Current report

    Report date 2026-06-25 · 0001171843-26-005168 · Items 2.05

  9. 8-K · Current report

    Report date 2026-06-25 · 0001171843-26-004333 · Items 2.05,7.01,9.01

  10. 4 · Ownership change

    Report date 2026-06-11 · 0000882796-26-000055

  11. 4 · Ownership change

    Report date 2026-06-11 · 0000882796-26-000053

  12. 4 · Ownership change

    Report date 2026-06-11 · 0000882796-26-000052

  13. 8-K · Current report

    Report date 2026-06-11 · 0001171843-26-004096 · Items 5.02,5.07,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-031238

  15. 8-K · Current report

    Report date 2026-05-06 · 0001171843-26-003052 · Items 2.02,7.01,9.01

  16. 8-K · Current report

    Report date 2026-05-04 · 0001171843-26-002960 · Items 7.01,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-06-11 · 0001628280-26-026822

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-012240

  19. 8-K · Current report

    Report date 2026-02-26 · 0001171843-26-001119 · Items 2.02,7.01,9.01

  20. 8-K/A · Current report

    Report date 2025-10-14 · 0001171843-26-000405 · Items 5.02

  21. 8-K · Current report

    Report date 2026-01-23 · 0001140361-26-002200 · Items 1.01,2.01,2.03,7.01,9.01

  22. 8-K · Current report

    Report date 2026-01-12 · 0001171843-26-000213 · Items 2.02,7.01,8.01,9.01

  23. 8-K · Current report

    Report date 2026-01-09 · 0001171843-26-000154 · Items 7.01

  24. 8-K · Current report

    Report date 2025-12-12 · 0001171843-25-007909 · Items 8.01,9.01

  25. 8-K · Current report

    Report date 2025-12-09 · 0001171843-25-007878 · Items 5.02

  26. 8-K · Current report

    Report date 2025-12-03 · 0001140361-25-044110 · Items 8.01,9.01

  27. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001628280-25-048785

  28. 8-K · Current report

    Report date 2025-11-03 · 0001171843-25-006881 · Items 2.02,7.01,9.01

  29. 8-K · Current report

    Report date 2025-10-14 · 0001140361-25-038031 · Items 1.01,2.02,5.02,8.01,9.01

  30. 8-K · Current report

    Report date 2025-10-01 · 0001140361-25-036875 · Items 1.01,8.01,9.01

  31. 8-K · Current report

    Report date 2025-08-11 · 0001171843-25-005265 · Items 5.02

  32. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001628280-25-037795

  33. 8-K · Current report

    Report date 2025-08-04 · 0001171843-25-004977 · Items 2.02,7.01,9.01

  34. 8-K · Current report

    Report date 2025-07-25 · 0001171843-25-004869 · Items 5.02,7.01,9.01

  35. 8-K · Current report

    Report date 2025-07-07 · 0001171843-25-004324 · Items 5.02,7.01,9.01

  36. 8-K · Current report

    Report date 2025-06-27 · 0001140361-25-024089 · Items 1.01,9.01

  37. 8-K · Current report

    Report date 2025-06-27 · 0001171843-25-004186 · Items 8.01,9.01

  38. 8-K · Current report

    Report date 2025-06-23 · 0001171843-25-004091 · Items 8.01

  39. 8-K · Current report

    Report date 2025-06-11 · 0001171843-25-003910 · Items 5.02,5.07,9.01

  40. 8-K · Current report

    Report date 2025-05-31 · 0001171843-25-003662 · Items 5.02

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 2 transaction rows2SGrant / award: 25 transaction rows25AExercise / conversion: 2 transaction rows2MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

29 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-11
2026-06-15
Milne Jill C.A · Grant / award
Acquired
Common Stock15294.00.0
2026-06-11
2026-06-15
Milne Jill C.A · Grant / award
Acquired
Automatic Stock Option Grant
Derivative security
33540.00.0
2026-06-11
2026-06-15
Galson Steven KA · Grant / award
Acquired
Common Stock15294.00.0
2026-06-11
2026-06-15
Galson Steven KA · Grant / award
Acquired
Automatic Stock Option Grant
Derivative security
33540.00.0
2026-06-11
2026-06-15
LEVIN ALAN GA · Grant / award
Acquired
Common Stock15294.00.0
2026-06-11
2026-06-15
LEVIN ALAN GA · Grant / award
Acquired
Automatic Stock Option Grant
Derivative security
33540.00.0
2026-06-11
2026-06-15
Frank StevenA · Grant / award
Acquired
Common Stock15294.00.0
2026-06-11
2026-06-15
Frank StevenA · Grant / award
Acquired
Automatic Stock Option Grant
Derivative security
33540.00.0
2026-06-11
2026-06-15
SANDERS MACHELLEA · Grant / award
Acquired
Common Stock15294.00.0
2026-06-11
2026-06-15
SANDERS MACHELLEA · Grant / award
Acquired
Automatic Stock Option Grant
Derivative security
33540.00.0
2026-06-11
2026-06-15
MILANO VINCENTA · Grant / award
Acquired
Common Stock15294.00.0
2026-06-11
2026-06-15
MILANO VINCENTA · Grant / award
Acquired
Automatic Stock Option Grant
Derivative security
33540.00.0
2026-06-11
2026-06-15
Stonehouse Jon PA · Grant / award
Acquired
Common Stock15294.00.0
2026-06-11
2026-06-15
Stonehouse Jon PA · Grant / award
Acquired
Automatic Stock Option Grant
Derivative security
33540.00.0
2026-06-11
2026-06-15
McKee Amy EA · Grant / award
Acquired
Common Stock15294.00.0
2026-06-11
2026-06-15
McKee Amy EA · Grant / award
Acquired
Automatic Stock Option Grant
Derivative security
33540.00.0
2026-06-11
2026-06-15
HEGGIE THERESAA · Grant / award
Acquired
Common Stock15294.00.0
2026-06-11
2026-06-15
HEGGIE THERESAA · Grant / award
Acquired
Automatic Stock Option Grant
Derivative security
33540.00.0
2026-05-29
2026-06-02
Milne Jill C.A · Grant / award
Acquired
Common Stock1262.08.91
2026-05-29
2026-06-02
Stonehouse Jon PA · Grant / award
Acquired
Common Stock631.08.91
2026-05-29
2026-06-02
McKee Amy EA · Grant / award
Acquired
Common Stock631.08.91
2026-05-29
2026-06-02
MILANO VINCENTA · Grant / award
Acquired
Common Stock1122.08.91
2026-05-29
2026-06-02
Frank StevenA · Grant / award
Acquired
Common Stock1262.08.91
2026-05-18
2026-05-19
McKee Amy ES · Sale
Disposed
Common Stock11180.08.97
2026-05-13
2026-05-15
Barnes Alane P
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock62500.09.54
2026-05-13
2026-05-15
Barnes Alane P
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock62500.05.04
2026-05-13
2026-05-15
Barnes Alane P
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Emp. Stock Option (Right to Buy)
Derivative security
62500.00.0
2026-04-06
2026-04-07
Menon SandeepA · Grant / award
Acquired
Common Stock205150.00.0
2026-04-06
2026-04-07
Menon SandeepA · Grant / award
Acquired
Emp. Stock Option (Right to Buy)
Derivative security
441350.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000882796BIOCRYST PHARMACEUTICALS INC

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300Z0INP1Z5NP6J59
GLEIF legal name
BioCryst Pharmaceuticals, Inc.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2023-08-04T17:37:57Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • BioCryst Pharmaceuticals · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$450.71M$479.77M
2023-12-31$331.41M$363.17M
2022-12-31$270.83M$308.96M
2021-12-31$157.17M$193.65M
2020-12-31$17.81M$22.98M
2019-12-31$48.84M$63.78M
2018-12-31$20.65M$27.46M
2017-12-31$25.19M$34.31M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗